| Dawn S Harbatkin, MD | |
|
3980 Sheridan Dr, Amherst, NY 14226-1727 | |
| (716) 250-2000 | |
| (716) 819-3821 |
| Full Name | Dawn S Harbatkin |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 30 Years |
| Location | 3980 Sheridan Dr, Amherst, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033119284 | NPI | - | NPPES |
| 202482 | Medicaid | NY |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dent Neurologic Group Llp | 1951298033 | 102 |
News Archive
In response to a recent New York Times article that questions why currently available medications designed to treat and prevent some cancers are being ignored, ECRI Institute, an independent nonprofit organization, is offering a roadmap to the evidence on Finasteride for Prevention of Prostate Cancer for free download.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that it will be presenting new in vivo data on its self-delivering rxRNA compounds at a number of upcoming scientific conferences, detailed below.
Ultradian Diagnostics LLC, an early-stage medical device company based in Rensselaer, New York, today announced the publication of clinical study results for Biologue, the Company's minimally invasive continuous glucose monitoring (CGM) system, in the November 2012 issue of the Journal of Diabetes Science and Technology.
The Measles Initiative partners - led by the American Red Cross, U.S. Centers for Disease Control and Prevention, the United Nations Foundation, UNICEF and the World Health Organization - will announce the latest achievement in global health during a press teleconference on Thursday, December 4, 2008 at 10:00 a.m. EST, 4:00pm CET.
› Verified 2 days ago
| Entity Name | Dent Neurologic Group Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497850911 PECOS PAC ID: 1951298033 Enrollment ID: O20040303000238 |
News Archive
In response to a recent New York Times article that questions why currently available medications designed to treat and prevent some cancers are being ignored, ECRI Institute, an independent nonprofit organization, is offering a roadmap to the evidence on Finasteride for Prevention of Prostate Cancer for free download.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that it will be presenting new in vivo data on its self-delivering rxRNA compounds at a number of upcoming scientific conferences, detailed below.
Ultradian Diagnostics LLC, an early-stage medical device company based in Rensselaer, New York, today announced the publication of clinical study results for Biologue, the Company's minimally invasive continuous glucose monitoring (CGM) system, in the November 2012 issue of the Journal of Diabetes Science and Technology.
The Measles Initiative partners - led by the American Red Cross, U.S. Centers for Disease Control and Prevention, the United Nations Foundation, UNICEF and the World Health Organization - will announce the latest achievement in global health during a press teleconference on Thursday, December 4, 2008 at 10:00 a.m. EST, 4:00pm CET.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dawn S Harbatkin, MD 3980 Sheridan Dr, Amherst, NY 14226-1727 Ph: (716) 250-2000 | Dawn S Harbatkin, MD 3980 Sheridan Dr, Amherst, NY 14226-1727 Ph: (716) 250-2000 |
News Archive
In response to a recent New York Times article that questions why currently available medications designed to treat and prevent some cancers are being ignored, ECRI Institute, an independent nonprofit organization, is offering a roadmap to the evidence on Finasteride for Prevention of Prostate Cancer for free download.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that it will be presenting new in vivo data on its self-delivering rxRNA compounds at a number of upcoming scientific conferences, detailed below.
Ultradian Diagnostics LLC, an early-stage medical device company based in Rensselaer, New York, today announced the publication of clinical study results for Biologue, the Company's minimally invasive continuous glucose monitoring (CGM) system, in the November 2012 issue of the Journal of Diabetes Science and Technology.
The Measles Initiative partners - led by the American Red Cross, U.S. Centers for Disease Control and Prevention, the United Nations Foundation, UNICEF and the World Health Organization - will announce the latest achievement in global health during a press teleconference on Thursday, December 4, 2008 at 10:00 a.m. EST, 4:00pm CET.
› Verified 2 days ago
Dr. Arthur F Weissman, MD Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 303 Roycroft Blvd, Amherst, NY 14226 Phone: 716-207-1873 |